MDM2 Gene Amplification
2 clinical trials · Condition
◉ Watch MDM2 Gene Amplification
| Record | Firm | Date |
|---|---|---|
| BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma (NCT06414434) | Michael Wagner, MD | 2024-09-30 |
| Milademetan in Advanced/Metastatic Solid Tumors (NCT05012397) | Rain Oncology Inc | 2021-11-01 |
Track MDM2 Gene Amplification automatically
Every clearance here is in the API, with alerts when new ones post.